Multi-Omics for Next-Generation Therapy Development

Gitanjali Rao's journey from a nine-year-old concerned about lead in water to a celebrated MIT student and the first recipient of the Stephen Hawking Junior Medal exemplifies a powerful model of scientific discovery driven by real-world problems and a commitment to open science.

Endogenous biomarkers are crucial for pharmaceutical development, offering insights into therapeutic effects and disease states. However, their inherent variability and structural similarities to other molecules present significant bioanalytical hurdles, impacting assay precision and accuracy.

Peptide therapeutics offer high potency and specificity, targeting complex biological pathways. However, their development is hampered by significant bioanalytical challenges.